美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MapLight Therapeutics, Inc.

18.03

+0.01500.08%

成交量：19.75萬

成交額：363.38萬

市值：8.18億

市盈率：-0.13

高：18.90

開：18.28

低：17.92

收：18.01

52周最高：21.55

52周最低：12.24

股本：4,537.30萬

流通股本：1,522.67萬

量比：1.63

換手率：1.30%

股息：- -

股息率：- -

每股收益(TTM):-133.7279

每股收益(LYR):-105.3781

淨資產收益率：--

總資產收益率：--

市淨率：-2.98

市盈率(LYR):-0.17

資料載入中...

總覽公司新聞資訊公告

Maplight Therapeutics, Inc.盤中異動股價大漲5.11%報18.50美元

Maplight Therapeutics, Inc.盤中異動快速上漲5.06%

MapLight Therapeutics阿爾茨海默病精神病藥物ML-007C-MA獲FDA快速通道認定

Aktis Oncology申請美國IPO，生物技術公司上市反彈

MapLight獲得合作化合物臨床開發和商業化的獨家權利

Sandboxaq與MapLight Therapeutics宣佈戰略合作，共同研發新型中樞神經系統療法

MapLight Therapeutics, Inc.：Leerink Partners啓動覆蓋，評級為「跑贏大盤」；目標價30美元

美國研究綜述-Bath & Body Works、鬆緊帶、沃爾瑪

美國研究綜述-Bath & Body Works、鬆緊帶、沃爾瑪

Maplight Therapeutics, Inc.盤中異動早盤大幅拉升6.70%報16.08美元

美股異動 | 生物醫藥企業Maplight Therapeutics(MPLT.US)登陸美股市場股價升逾15.8%

異動解讀 | MapLight Therapeutics首日掛牌納斯達克，股價盤中大漲19.53%

藥物開發商 MapLight 在美國的首次公開募股定價為每股 17 美元

MapLight Therapeutics(MPLT.US)擬募資2.51億美元美政府停擺下啓用罕見法律條款推進上市流程

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MPLT/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MPLT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":18.025,"timestamp":1772658000000,"preClose":18.01,"halted":0,"volume":197548,"delay":0,"changeRate":0.0008328706274290402,"floatShares":15226707,"shares":45373000,"eps":-133.72789,"marketStatus":"盤前交易","change":0.015,"latestTime":"03-05 07:31:27 EST","open":18.28,"high":18.895,"low":17.92,"amount":3633788.628,"amplitude":0.054137,"askPrice":19.86,"askSize":100,"bidPrice":7.21,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-133.72789,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772721000000},"marketStatusCode":1,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":18.025,"postHourTrading":{"tag":"盘后","latestPrice":18.025,"preClose":18.025,"latestTime":"16:10 EST","volume":1633,"amount":29434.825,"timestamp":1772658604198,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.632124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","floatShares":15226707,"roa":"--","roe":"--","lyrEps":-105.378114,"volumeRatio":1.632124,"shares":45373000,"dividePrice":0,"high":18.895,"amplitude":0.054137,"preClose":18.01,"low":17.92,"week52Low":12.24,"pbRate":"-2.98","week52High":21.55,"institutionHeld":0,"latestPrice":18.025,"committee":0.333333,"eps":-133.72789,"divideRate":0,"volume":197548,"delay":0,"ttmEps":-133.72789,"open":18.28,"prevYearClose":17.565,"prevWeekClose":17.27,"prevMonthClose":17.27,"prevQuarterClose":17.565,"fiveDayClose":17.63,"twentyDayClose":17.11,"sixtyDayClose":18.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MPLT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MPLT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MPLT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1763787600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MPLT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MPLT","date":"2026-03-04","current":-0.134789,"percent":0.356322,"low":-8.946167,"twenty":-7.975131,"median":-7.532944,"eighty":-7.122133,"high":-6.048324,"avg":-7.500949,"sd":0.61844,"marketCap":785982010},"quantilePoints":[{"date":"2025-10-31","current":-8.673514,"twenty":-8.310978,"median":-7.61973,"eighty":-7.489746,"marketCap":801692922},{"date":"2025-11-07","current":-7.620605,"twenty":-8.035178,"median":-7.644213,"eighty":-7.545137,"marketCap":704372551},{"date":"2025-11-14","current":-6.742394,"twenty":-7.98511,"median":-7.554503,"eighty":-7.23627,"marketCap":623199506},{"date":"2025-11-21","current":-6.274959,"twenty":-7.73109,"median":-7.394197,"eighty":-6.810384,"marketCap":579994498},{"date":"2025-11-28","current":-6.435493,"twenty":-7.639491,"median":-7.190943,"eighty":-6.54881,"marketCap":594832581},{"date":"2025-12-05","current":-7.783335,"twenty":-7.714027,"median":-7.115398,"eighty":-6.435493,"marketCap":800383679},{"date":"2025-12-12","current":-8.528142,"twenty":-7.986054,"median":-7.394197,"eighty":-6.45249,"marketCap":876974375},{"date":"2025-12-19","current":-8.462361,"twenty":-8.266224,"median":-7.554503,"eighty":-6.54881,"marketCap":870209954},{"date":"2025-12-26","current":-7.689969,"twenty":-8.289163,"median":-7.620605,"eighty":-6.624355,"marketCap":790782566},{"date":"2026-01-02","current":-7.454432,"twenty":-8.20424,"median":-7.61973,"eighty":-6.670627,"marketCap":766561577},{"date":"2026-01-09","current":-7.295285,"twenty":-8.111814,"median":-7.53948,"eighty":-6.75706,"marketCap":750196044},{"date":"2026-01-16","current":-7.84275,"twenty":-8.074467,"median":-7.609335,"eighty":-6.818055,"marketCap":806493478},{"date":"2026-01-23","current":-7.885189,"twenty":-7.999774,"median":-7.554503,"eighty":-6.827382,"marketCap":810857620},{"date":"2026-01-30","current":-7.885189,"twenty":-8.004018,"median":-7.620167,"eighty":-6.893484,"marketCap":810857620},{"date":"2026-02-06","current":-6.662942,"twenty":-7.999774,"median":-7.609335,"eighty":-6.893484,"marketCap":685170325},{"date":"2026-02-13","current":-7.308017,"twenty":-7.988887,"median":-7.547968,"eighty":-7.020967,"marketCap":751505286},{"date":"2026-02-20","current":-7.605091,"twenty":-7.988887,"median":-7.532944,"eighty":-7.096512,"marketCap":782054282},{"date":"2026-02-27","current":-7.392895,"twenty":-7.98511,"median":-7.541432,"eighty":-7.116712,"marketCap":760233571},{"date":"2026-03-04","current":-7.643286,"twenty":-7.975131,"median":-7.532944,"eighty":-7.122133,"marketCap":785982010}],"updateTime":1772708345353},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MPLT\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617552908","title":"Maplight Therapeutics, Inc.盤中異動 股價大漲5.11%報18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617552908?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 03:41","pubTimestamp":1772566875,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时41分，Maplight Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报18.50美元/股，成交量7.8101万股，换手率0.17%，振幅7.81%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.80%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Hcw Biologics Inc.涨幅较大，Edesa Biotech, Inc.、Onconetix, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为306.82%、199.87%、139.79%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.82%、43.99%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304034115a447d7f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304034115a447d7f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4539","MPLT"],"gpt_icon":0},{"id":"2606739773","title":"Maplight Therapeutics, Inc.盤中異動 快速上漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606739773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606739773?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 00:41","pubTimestamp":1769532107,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日00时41分，Maplight Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报18.89美元/股，成交量7.608万股，换手率0.17%，振幅6.34%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Lisata Therapeutics, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为2036.13%、748.47%、230.41%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、37.46%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","MPLT","LENZ","BK4007"],"gpt_icon":0},{"id":"1167154321","title":"MapLight Therapeutics阿爾茨海默病精神病藥物ML-007C-MA獲FDA快速通道認定","url":"https://stock-news.laohu8.com/highlight/detail?id=1167154321","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167154321?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:02","pubTimestamp":1767614544,"startTime":"0","endTime":"0","summary":"生物制药公司MapLight Therapeutics宣布，其针对阿尔茨海默病精神病症状的候选药物ML-007C-MA已获得美国食品药品监督管理局（FDA）授予的快速通道资格。这一认定将加速该药物的临床开发与审评进程，为患者提供更早获得创新疗法的可能。\nML-007C-MA是一种针对特定神经机制的新型治疗药物，旨在缓解阿尔茨海默病患者常见的精神病性症状，如幻觉、妄想和激越行为。快速通道资格的获得，意味着FDA认可该药物在未满足医疗需求领域的潜在价值，并将通过更频繁的沟通、滚动审评等机制支持其研发。\n公司表示将积极推进后续临床试验，力争早日为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"gpt_icon":0},{"id":"2592118027","title":"Aktis Oncology申請美國IPO，生物技術公司上市反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118027","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118027?lang=zh_tw&edition=fundamental","pubTime":"2025-12-20 06:45","pubTimestamp":1766184351,"startTime":"0","endTime":"0","summary":"Aktis Oncology申请美国IPO，生物技术公司上市反弹路透12月19日 - Aktis Oncology公司周五在美国提交了首次公开募股申请，生物技术行业的股市上市在经历了放缓后出现反弹。Aktis Oncology 公司由生物技术投资者托德-福里于 2020 年 8 月共同创立，目前正在开发治疗多种实体瘤的药物。Aktis Oncology 的主要候选药物 AKY-1189 正在进行早期研究，以治疗某些实体瘤，包括一种晚期膀胱癌、乳腺癌和结直肠癌。Aktis Oncology 公司的前身是 HotKnot Therapeutics 公司，将在纳斯达克上市，股票代码为 \"AKTS\"。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4T3XP1JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","LU0320765489.SGD","BK4585","LU0648001328.SGD","LU0648000940.SGD","BK4534","LU0321505439.SGD","EVMN","LU1201861249.SGD","LU1880398554.USD","LU0306807586.USD","LU0208291251.USD","OWL","LU1162221912.USD","IE00BBT3K403.USD","LU0256863811.USD","LU0310800965.SGD","LU0130103400.USD","LU0477156797.USD","LU0130102774.USD","IE00BLSP4452.SGD","LU0203347892.USD","LU0052756011.USD","LU0980610538.SGD","IE0034235188.USD","LU2129689431.USD","IE00BZ1G4Q59.USD","LU0128525689.USD","LU0234572021.USD","BAC","LU1363072403.SGD","LU1804176565.USD","BK4553","LU0256863902.USD","LU1201861165.SGD","LU0130517989.USD","IE0001KFT4U8.USD","LU0306806265.USD","LU1668664300.SGD","MNSH","IE00BKVL7J92.USD","MPLT","LU1883839398.USD","LU1894683348.USD","LU2129689514.USD","LBRX","LU1791807156.HKD","LU1074936037.SGD","LU1035773651.USD","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"1119775214","title":"MapLight獲得合作化合物臨床開發和商業化的獨家權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1119775214","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119775214?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 20:06","pubTimestamp":1765886772,"startTime":"0","endTime":"0","summary":"MapLight获得合作化合物临床开发和商业化的独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"gpt_icon":0},{"id":"1100462384","title":"Sandboxaq與MapLight Therapeutics宣佈戰略合作，共同研發新型中樞神經系統療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1100462384","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100462384?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 20:01","pubTimestamp":1765886484,"startTime":"0","endTime":"0","summary":"Sandboxaq与MapLight Therapeutics宣布战略合作，共同研发新型中枢神经系统疗法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"gpt_icon":0},{"id":"1192124876","title":"MapLight Therapeutics, Inc.：Leerink Partners啓動覆蓋，評級為「跑贏大盤」；目標價30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192124876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192124876?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 20:17","pubTimestamp":1763727449,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.：Leerink Partners启动覆盖，评级为“跑赢大盘”；目标价30美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"gpt_icon":0},{"id":"2585316192","title":"美國研究綜述-Bath & Body Works、鬆緊帶、沃爾瑪","url":"https://stock-news.laohu8.com/highlight/detail?id=2585316192","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585316192?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 15:06","pubTimestamp":1763708806,"startTime":"0","endTime":"0","summary":"美国研究综述-Bath & Body Works、松紧带、沃尔玛路透11月21日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Bath & Body Works、Elastic 和沃尔玛。要闻 * Bath & Body Works Inc BBWI.N：巴克莱将其目标价从28美元下调至18美元 * Elastic NV ESTC.N：巴克莱将目标价从125美元下调至107美元 * Exact Sciences Corp EXAS.O：BTIG将目标价从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL4T3WX0IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0557290698.USD","LU1506573853.SGD","GBDC","LU0006306889.USD","LU0868494708.USD","LU2089284900.SGD","TRGP","BBWI","BK4585","LU2098885051.SGD","WSM","PPG","LU1989764748.USD","ROST","LU0889565833.HKD","LU2247934214.USD","BK4567","IPAR","DKS","BK4167","EXAS","LU0265550359.USD","LU2357305700.SGD","MPLT","WMT","BK4082","LU0198837287.USD","PODD","LU1988902786.USD","BK4533","VEEV","LU0820562030.AUD","WMG","BIIB","LU0689626769.HKD","CRM","LU2471134796.USD","LU1116320737.USD","HRL","ELAN","LOW","LU1815333072.USD","GUTS","LU1585245621.USD","LU0868494617.USD","ESTC","IE00B19Z9P08.USD","LU0211327993.USD","BK4212","ZTS"],"gpt_icon":0},{"id":"2585192315","title":"美國研究綜述-Bath & Body Works、鬆緊帶、沃爾瑪","url":"https://stock-news.laohu8.com/highlight/detail?id=2585192315","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585192315?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 15:06","pubTimestamp":1763708806,"startTime":"0","endTime":"0","summary":"美国研究综述-Bath & Body Works、松紧带、沃尔玛路透11月21日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Bath & Body Works、Elastic 和沃尔玛。要闻 * Bath & Body Works Inc BBWI.N：巴克莱将其目标价从28美元下调至18美元 * Elastic NV ESTC.N：巴克莱将目标价从125美元下调至107美元 * Exact Sciences Corp EXAS.O：BTIG将目标价从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL4S3WX0IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WSM","ZTS","LU1823568750.SGD","BIIB","BK4581","CRM","LOW","LU2471134879.HKD","LU1496350171.SGD","DKS","LU2361045086.USD","WMG","IE0034390439.USD","ESTC","BBWI","LU0345774391.USD","LU0640476718.USD","LU0642271901.SGD","LU1316542783.SGD","LU1720051108.HKD","MPLT","TRGP","VEEV","GUTS","LU2324357040.USD","LU2089283258.USD","ROST","IPAR","EXAS","LU2098885051.SGD","LU0477156953.USD","IE00BQXX3D17.EUR","LU0081259029.USD","HRL","LU0820562030.AUD","IE00B19Z8X17.USD","LU0130517989.USD","PODD","BK4585","LU2458330243.SGD","GBDC","LU1778281490.HKD","WMT","ELAN","LU0314106906.USD","IE00BQXX3C00.GBP","LU2308191902.HKD","LU0889566641.SGD","PPG","LU0957791311.USD"],"gpt_icon":0},{"id":"2583580662","title":"Maplight Therapeutics, Inc.盤中異動 早盤大幅拉升6.70%報16.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583580662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583580662?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 22:34","pubTimestamp":1762958081,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时34分，Maplight Therapeutics, Inc.股票出现异动，股价大幅拉升6.70%。截至发稿，该股报16.08美元/股，成交量3256股，换手率0.01%，振幅0.00%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为4586.14%、304.64%、64.17%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.，振幅分别为46.48%、33.67%、14.86%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MPLT","BK4539","BK4007"],"gpt_icon":0},{"id":"2578625444","title":"美股異動 | 生物醫藥企業Maplight Therapeutics(MPLT.US)登陸美股市場 股價升逾15.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578625444","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578625444?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 23:58","pubTimestamp":1761580713,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，生物医药企业Maplight Therapeutics(MPLT.US)登陆美股市场，截至发稿，该股涨超15.8%，报19.7美元。IPO价格为17美元。MapLight由国际知名的精神病学和神经科学研究领袖创立，旨在解决患者缺乏针对特定神经回路的药物疗法的问题。MapLight称，其平台能够识别与疾病有因果关系的神经回路，并针对这些回路进行治疗调控。该公司已开发出一系列候选产品，用于治疗一些最具挑战性的中枢神经系统疾病，例如精神分裂症、阿尔茨海默病和自闭症谱系障碍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","BK4539","BK4007","BK4139","MPLT","161726","LENZ"],"gpt_icon":0},{"id":"1142199633","title":"異動解讀 | MapLight Therapeutics首日掛牌納斯達克，股價盤中大漲19.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142199633","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142199633?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 23:50","pubTimestamp":1761580221,"startTime":"0","endTime":"0","summary":"生物制药公司MapLight Therapeutics今日在纳斯达克挂牌上市，股价表现强劲，盘中大涨19.53%。据悉，MapLight Therapeutics的股票在首个交易日开盘价较发行价高出11.8%。作为一家专注于药物开发的生物科技公司，MapLight Therapeutics的成功上市不仅为公司带来了可观的融资，也为其未来的研发和业务扩张奠定了坚实的基础。分析人士指出，MapLight Therapeutics的股价强势上涨反映了市场对生物医药行业的持续看好，特别是在当前全球健康意识不断提升的背景下。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MPLT"],"gpt_icon":0},{"id":"2578765098","title":"藥物開發商 MapLight 在美國的首次公開募股定價為每股 17 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578765098","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578765098?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 05:37","pubTimestamp":1761514637,"startTime":"0","endTime":"0","summary":"药物开发商 MapLight 在美国的首次公开募股定价为每股 17 美元路透10月26日 - 由诺和诺德控股公司（Novo Holdings）支持的临床阶段生物技术公司MapLight Therapeutics MPLT.O周日表示，其美国首次公开募股的定价为每股17美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251026:nL4T3W7065:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"gpt_icon":0},{"id":"2573969662","title":"MapLight Therapeutics(MPLT.US)擬募資2.51億美元 美政府停擺下啓用罕見法律條款推進上市流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2573969662","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573969662?lang=zh_tw&edition=fundamental","pubTime":"2025-10-07 23:19","pubTimestamp":1759850363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，总部位于美国加州红木城的生物技术公司MapLight Therapeutics周一公布首次公开募股条款，计划通过发行1480万股普通股，以每股17美元的价格募集约2.51亿美元。为绕过这一障碍，MapLight决定依据《1933年证券法》第8条的罕见条款推进上市流程。MapLight表示，计划在20天后正式定价，但若SEC在10月26日前恢复正常运作，公司将重新评估是否继续依赖该条款。MapLight成立于2018年，计划在纳斯达克挂牌上市，股票代码为“MPLT”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4539","MPLT","BK4007","BK4139"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}